Meeting
2019 ASCO Annual Meeting
The prognostic role of progesterone receptor in patients with rapidly proliferating, hormone receptor-positive early breast cancer.
Authors
Sara Bravaccini
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
Sara Bravaccini , Giuseppe Bronte , Emanuela Scarpi , Sara Ravaioli , Maria Maddalena Tumedei , Roberta Maltoni , Maurizio Puccetti , Anita Mangia , Dino Amadori , Andrea Rocca
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Adjuvant Therapy
Citation
J Clin Oncol 37, 2019 (suppl; abstr 545)
DOI
10.1200/JCO.2019.37.15_suppl.545
Abstract #
545
Poster Bd #
37
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Impact of body mass index (BMI) on the prognosis of women with high-risk early breast cancer (BC) receiving adjuvant chemotherapy (CT).
First Author: Alessandra Gennari
Poster
2012 ASCO Annual Meeting
Neoadjuvant epirubicin, gemcitabine, and docetaxel for primary breast cancer: Survival and prognostic factors in two consecutive neoadjuvant phase I/II trials.
First Author: Frederik Marme
Poster
2011 Breast Cancer Symposium
Prognosis by breast cancer subtypes in patients treated with adjuvant chemotherapy in a clinical trial.
First Author: A. M. G. Ali
Poster
2023 ASCO Annual Meeting
Evolution of HER2 scores after neoadjuvant systemic therapy in breast cancer.
First Author: Esther G Chong